MedTrace Logo

Cerebral NIRS Monitoring During Anesthesia in Neonates and Infants

NCT04132414 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-09-29

No results posted yet for this study

Summary

The brain is a very vulnerable organ, especially in premature babies, newborns and infants. However, during anesthesia, the oxygenation of the brain can only be monitored indirectly and insufficiently. Near-infrared spectroscopy (NIRS) is an established monitoring method in other areas (e.g., neonatology, cardiac anesthesia), which provides non-invasive information about the regional oxygen supply of the brain. The integration of this monitoring device into the anaesthesiological care for neonates and infants could reduce the risk of cerebral hypoxia. The planned study investigates whether the use of NIRS in anesthetized children up to 6 months can prevent or influence the occurrence of cerebral hypoxia.

Conditions

  • Cerebral Oxygenation

Interventions

DIAGNOSTIC_TEST

NIRS open

Treatment according to protocol in phases of cerebral hypoxia.

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Stefan Heschl, M.D., Ph.D. · Medical University of Graz

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2023-06-30
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04132414 on ClinicalTrials.gov